| 查看: 492 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题，病人别嘌醇0.1 bid 后尿酸仍在五百多，现在建议苯溴马隆口服，但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了，没有这方面的经验，请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
回复此楼» 猜你喜欢
最近网站变化
已经有8人回复
-
应该是依托单位先拿到结果吧
已经有2人回复
-
法医学论文润色/翻译怎么收费?
已经有106人回复
-
d点击grid/output/Save GPF后，
已经有0人回复
-
301分临床医学求调剂
已经有0人回复
-
医学口青基，明天开始会评，祈福~
已经有41人回复
-
郑州大学招收2026年外科学博士研究生
已经有0人回复
-
中国医科大学医学技术专硕（105800）接收调剂 生物医学工程方向
已经有0人回复
» 本主题相关商家推荐: (我也要在这里推广)
